FDA and FTC regulatory action in June

FDA and FTC regulatory action in June

Here's the latest update of warning letters and crackdowns coming from the FDA and the FTC. 

Untitled Story

Apotex Pharmachem India Pvt Ltd. 6/16/14 June 19, 2014 · www.fda.gov · During our January 27, 2014 through January 31, 2014 inspection of your pharmaceutical manufacturing facility, Apotex Pharmachem India Pvt. Ltd. located at Plot # 1A Bommasandra Ind. Area, 4th Phase, Jigani Link Road, Bangalore, India, investigators from the U.S. Food and Drug Administration (FDA) identified significant deviations from current good manufacturing practice (CGMP) for the manufacture of active pharmaceutical ingredients (APIs). These deviations cause your APIs to be ...

View "Untitled Story" on Spundge
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.